Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping

Ran Kornowski, Donald S. Baim, Jeffrey W. Moses, Mun K. Hong, Roger J. Laham, Shmuel Fuchs, Robert Hendel, Deborah Wallace, David J. Cohen, Robert O. Bonow, Richard E. Kuntz, Martin B. Leon

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background - Direct myocardial revascularization (DMR) has been examined as an alternative treatment for patients with chronic refractory myocardial ischemic syndromes who are not candidates for conventional coronary revascularization. Methods and Results - We used left ventricular electromagnetic guidance in 77 patients with chronic refractory angina (56 men, mean age 61±11 years, ejection fraction 0.48±0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse. Procedural success (laser channels placed in prespecified target zones) was achieved in 76 of 77 patients with an average of 26±10 channels (range 11 to 50 channels). The rate of major in-hospital cardiac adverse events was 2.6%, with no deaths or emergency operations, 1 patient with postprocedural pericardiocentesis, and 1 patient with minor embolic stroke. The rate of out-of-hospital adverse cardiac events (up to 6 months) was 2.6%, with 1 patient with myocardial infarction and 1 patient with stroke. Exercise duration after DMR increased from 387±179 to 454±166 seconds at 1 month and to 479±161 seconds at 6 months (P=0.0001). The time to onset of angina increased from 293±167 to 377±176 seconds at 1 month and to 414±169 seconds at 6 months (P=0.0001). Importantly, the time to ST-segment depression (≥ 1 mm) also increased from 327±178 to 400±172 seconds at 1 month and to 436±175 seconds at 6 months (P=0.001). Angina (Canadian Cardiovascular Society classification) improved from 3.3±0.5 to 2.0±1.2 at 6 months (P<0.001). Nuclear perfusion imaging studies with a dual-isotope technique, however, showed no significant improvements at 1 or 6 months. Conclusions - Percutaneous DMR guided by left ventricular mapping is feasible and safe and reveals improved angina and prolonged exercise duration for up to a 6-month follow-up.

Original languageEnglish
Pages (from-to)1120-1125
Number of pages6
JournalCirculation
Volume102
Issue number10
StatePublished - Sep 5 2000
Externally publishedYes

Fingerprint

Myocardial Revascularization
Lasers
Stroke
Exercise
Pericardiocentesis
Perfusion Imaging
Electromagnetic Phenomena
Solid-State Lasers
Isotopes
Emergencies
Myocardial Infarction

Keywords

  • Angina
  • Ischemia
  • Lasers
  • Myocardium
  • Revascularization

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Kornowski, R., Baim, D. S., Moses, J. W., Hong, M. K., Laham, R. J., Fuchs, S., ... Leon, M. B. (2000). Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. Circulation, 102(10), 1120-1125.

Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. / Kornowski, Ran; Baim, Donald S.; Moses, Jeffrey W.; Hong, Mun K.; Laham, Roger J.; Fuchs, Shmuel; Hendel, Robert; Wallace, Deborah; Cohen, David J.; Bonow, Robert O.; Kuntz, Richard E.; Leon, Martin B.

In: Circulation, Vol. 102, No. 10, 05.09.2000, p. 1120-1125.

Research output: Contribution to journalArticle

Kornowski, R, Baim, DS, Moses, JW, Hong, MK, Laham, RJ, Fuchs, S, Hendel, R, Wallace, D, Cohen, DJ, Bonow, RO, Kuntz, RE & Leon, MB 2000, 'Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping', Circulation, vol. 102, no. 10, pp. 1120-1125.
Kornowski, Ran ; Baim, Donald S. ; Moses, Jeffrey W. ; Hong, Mun K. ; Laham, Roger J. ; Fuchs, Shmuel ; Hendel, Robert ; Wallace, Deborah ; Cohen, David J. ; Bonow, Robert O. ; Kuntz, Richard E. ; Leon, Martin B. / Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping. In: Circulation. 2000 ; Vol. 102, No. 10. pp. 1120-1125.
@article{d18f0d55abc44d97adda2616c935264b,
title = "Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping",
abstract = "Background - Direct myocardial revascularization (DMR) has been examined as an alternative treatment for patients with chronic refractory myocardial ischemic syndromes who are not candidates for conventional coronary revascularization. Methods and Results - We used left ventricular electromagnetic guidance in 77 patients with chronic refractory angina (56 men, mean age 61±11 years, ejection fraction 0.48±0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse. Procedural success (laser channels placed in prespecified target zones) was achieved in 76 of 77 patients with an average of 26±10 channels (range 11 to 50 channels). The rate of major in-hospital cardiac adverse events was 2.6{\%}, with no deaths or emergency operations, 1 patient with postprocedural pericardiocentesis, and 1 patient with minor embolic stroke. The rate of out-of-hospital adverse cardiac events (up to 6 months) was 2.6{\%}, with 1 patient with myocardial infarction and 1 patient with stroke. Exercise duration after DMR increased from 387±179 to 454±166 seconds at 1 month and to 479±161 seconds at 6 months (P=0.0001). The time to onset of angina increased from 293±167 to 377±176 seconds at 1 month and to 414±169 seconds at 6 months (P=0.0001). Importantly, the time to ST-segment depression (≥ 1 mm) also increased from 327±178 to 400±172 seconds at 1 month and to 436±175 seconds at 6 months (P=0.001). Angina (Canadian Cardiovascular Society classification) improved from 3.3±0.5 to 2.0±1.2 at 6 months (P<0.001). Nuclear perfusion imaging studies with a dual-isotope technique, however, showed no significant improvements at 1 or 6 months. Conclusions - Percutaneous DMR guided by left ventricular mapping is feasible and safe and reveals improved angina and prolonged exercise duration for up to a 6-month follow-up.",
keywords = "Angina, Ischemia, Lasers, Myocardium, Revascularization",
author = "Ran Kornowski and Baim, {Donald S.} and Moses, {Jeffrey W.} and Hong, {Mun K.} and Laham, {Roger J.} and Shmuel Fuchs and Robert Hendel and Deborah Wallace and Cohen, {David J.} and Bonow, {Robert O.} and Kuntz, {Richard E.} and Leon, {Martin B.}",
year = "2000",
month = "9",
day = "5",
language = "English",
volume = "102",
pages = "1120--1125",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping

AU - Kornowski, Ran

AU - Baim, Donald S.

AU - Moses, Jeffrey W.

AU - Hong, Mun K.

AU - Laham, Roger J.

AU - Fuchs, Shmuel

AU - Hendel, Robert

AU - Wallace, Deborah

AU - Cohen, David J.

AU - Bonow, Robert O.

AU - Kuntz, Richard E.

AU - Leon, Martin B.

PY - 2000/9/5

Y1 - 2000/9/5

N2 - Background - Direct myocardial revascularization (DMR) has been examined as an alternative treatment for patients with chronic refractory myocardial ischemic syndromes who are not candidates for conventional coronary revascularization. Methods and Results - We used left ventricular electromagnetic guidance in 77 patients with chronic refractory angina (56 men, mean age 61±11 years, ejection fraction 0.48±0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse. Procedural success (laser channels placed in prespecified target zones) was achieved in 76 of 77 patients with an average of 26±10 channels (range 11 to 50 channels). The rate of major in-hospital cardiac adverse events was 2.6%, with no deaths or emergency operations, 1 patient with postprocedural pericardiocentesis, and 1 patient with minor embolic stroke. The rate of out-of-hospital adverse cardiac events (up to 6 months) was 2.6%, with 1 patient with myocardial infarction and 1 patient with stroke. Exercise duration after DMR increased from 387±179 to 454±166 seconds at 1 month and to 479±161 seconds at 6 months (P=0.0001). The time to onset of angina increased from 293±167 to 377±176 seconds at 1 month and to 414±169 seconds at 6 months (P=0.0001). Importantly, the time to ST-segment depression (≥ 1 mm) also increased from 327±178 to 400±172 seconds at 1 month and to 436±175 seconds at 6 months (P=0.001). Angina (Canadian Cardiovascular Society classification) improved from 3.3±0.5 to 2.0±1.2 at 6 months (P<0.001). Nuclear perfusion imaging studies with a dual-isotope technique, however, showed no significant improvements at 1 or 6 months. Conclusions - Percutaneous DMR guided by left ventricular mapping is feasible and safe and reveals improved angina and prolonged exercise duration for up to a 6-month follow-up.

AB - Background - Direct myocardial revascularization (DMR) has been examined as an alternative treatment for patients with chronic refractory myocardial ischemic syndromes who are not candidates for conventional coronary revascularization. Methods and Results - We used left ventricular electromagnetic guidance in 77 patients with chronic refractory angina (56 men, mean age 61±11 years, ejection fraction 0.48±0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse. Procedural success (laser channels placed in prespecified target zones) was achieved in 76 of 77 patients with an average of 26±10 channels (range 11 to 50 channels). The rate of major in-hospital cardiac adverse events was 2.6%, with no deaths or emergency operations, 1 patient with postprocedural pericardiocentesis, and 1 patient with minor embolic stroke. The rate of out-of-hospital adverse cardiac events (up to 6 months) was 2.6%, with 1 patient with myocardial infarction and 1 patient with stroke. Exercise duration after DMR increased from 387±179 to 454±166 seconds at 1 month and to 479±161 seconds at 6 months (P=0.0001). The time to onset of angina increased from 293±167 to 377±176 seconds at 1 month and to 414±169 seconds at 6 months (P=0.0001). Importantly, the time to ST-segment depression (≥ 1 mm) also increased from 327±178 to 400±172 seconds at 1 month and to 436±175 seconds at 6 months (P=0.001). Angina (Canadian Cardiovascular Society classification) improved from 3.3±0.5 to 2.0±1.2 at 6 months (P<0.001). Nuclear perfusion imaging studies with a dual-isotope technique, however, showed no significant improvements at 1 or 6 months. Conclusions - Percutaneous DMR guided by left ventricular mapping is feasible and safe and reveals improved angina and prolonged exercise duration for up to a 6-month follow-up.

KW - Angina

KW - Ischemia

KW - Lasers

KW - Myocardium

KW - Revascularization

UR - http://www.scopus.com/inward/record.url?scp=0034609522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034609522&partnerID=8YFLogxK

M3 - Article

C2 - 10973840

AN - SCOPUS:0034609522

VL - 102

SP - 1120

EP - 1125

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 10

ER -